A Pilot Study of the Effect of Sodium Thiosulfate on Urinary Lithogenicity and Associated Metabolic Acid Load in Non-Stone Formers and Stone Formers with Hypercalciuria

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Okonkwo, Onyeka W ^a   Batwara, Ruchika ^b   Granja, Ignacio ^c   Asplin, John R ^c   Goldfarb, David S ^a,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^c LithoLink Corporation   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; BICARBONATE; CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATE; CITRIC ACID; SODIUM THIOSULFATE; SULFATE; URIC ACID;

ADULT; AGED; AMMONIA URINE LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM STONE; CITRATE EXCRETION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; DRUG EFFECT; FEMALE; HUMAN; HYPERCALCIURIA; MALE; METABOLIC ACIDOSIS; NEPHROLITHIASIS; NONHUMAN; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; STONE FORMATION; SULFATE EXCRETION; URINALYSIS; URINARY EXCRETION; URINARY LITHOGENICITY; URINE LEVEL; URINE PH; UROLITHIASIS;

ACIDS; ADULT; FEMALE; HUMANS; HYPERCALCIURIA; KIDNEY CALCULI; MALE; PILOT PROJECTS; THIOSULFATES;

RATTUS;

EID: 84875982203     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060380     Document Type: Article

References (24)

1. Hall AH, Dart R, Bogdan G, (2007) Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med 49: 806-813.
2. Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, et al. (1982) Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 97: 845-851.
3. Hackett BC, McAleer MA, Sheehan G, Powell FC, O'Donnell BF, (2009) Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate. Clin Exp Dermatol 34: 39-42.
4. Cicone JS, Petronis JB, Embert CD, Spector DA, (2004) Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43: 1104-1108.
5. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, et al. (2009) Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 20: 1246-1253.
6. Yatzidis H, (1985) Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 23: 63-67.
7. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC, (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823.
8. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, et al. (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346: 77-84.
9. Lingeman J, Mardis H, Kahnoski R, Goldfarb DS, Lacy S, et al. (1998) Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol 160: 1629-1634.
10. Finlayson B (1977) Calcium stones: some physical and clinical aspects. In: David DS, editor. Calcium Metabolism in Renal Failure and Nephrolithiasis. New York: John Wiley & Sons. 337-382.
11. Brucculeri M, Cheigh J, Bauer G, Serur D, (2005) Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 18: 431-434.
12. Adirekkiat S, Sumethkul V, Ingsathit A, Domrongkitchaiporn S, Phakdeekitcharoen B, et al. (2010) Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol Dial Transplant 25: 1923-1929.
13. Selk N, Rodby RA, (2011) Unexpectedly severe metabolic acidosis associated with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy. Sem Dial 24: 85-88.
14. Bartholomew TC, Powell GM, Dodgson KS, Curtis CG, (1980) Oxidation of sodium sulphide by rat liver, lungs and kidney. Biochem Pharmacol 29: 2431-2437.
15. Sauve V, Roversi P, Leath KJ, Garman EF, Antrobus R, et al. (2009) Mechanism for the hydrolysis of a sulfur-sulfur bond based on the crystal structure of the thiosulfohydrolase SoxB. J Biol Chem 284: 21707-21718.
16. Gilman A, Philips FS, Koelle ES, (1946) The renal clearance of thiosulfate with observations on its volume distribution. Am J Physiol 146: 348-357.
17. Bushinsky DA, Grynpas MD, Asplin JR, (2001) Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 59: 1415-1423.
18. LaGrange CA, Lele SM, Pais VM Jr, (2009) The effect of sodium thiosulfate administration on nephrocalcinosis in a rat model. J Endourol 23: 529-533.
19. Thorpe MP, Evans EM, (2011) Dietary protein and bone health: harmonizing conflicting theories. Nutr Rev 69: 215-230.
20. Asplin JR, Bauer KA, Kinder J, Muller G, Coe BJ, et al. (2003) Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 63: 662-669.
21. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, et al. (2008) Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 74: 1444-1453.
22. Goldfarb DS, (2012) A woman with recurrent calcium phosphate kidney stones. Clin J Am Soc Nephrol 7: 1172-8.
23. Preminger GM, Sakhaee K, Skurla C, Pak CY, (1985) Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134: 20-23.
24. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS, (1999) Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55: 234-243.